Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,485 | -2,513 | -1,407 | -11,048 | -8,499 |
| Depreciation Amortization | 3 | 2 | 1 | 113 | 84 |
| Accounts receivable | 343 | 440 | 235 | -357 | -607 |
| Other Working Capital | -423 | -268 | -394 | -821 | -1,569 |
| Other Operating Activity | -167 | -309 | -160 | 723 | 891 |
| Operating Cash Flow | $-4,729 | $-2,648 | $-1,725 | $-11,389 | $-9,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 3 | 3 | 1 | -2 | -6 |
| Investing Cash Flow | $3 | $3 | $1 | $-2 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 365 |
| Common Stock Issued | 13,682 | 13,965 | 14,408 | 7,931 | 7,929 |
| Other Financing Activity | 62 | -50 | -393 | 0 | -365 |
| Financing Cash Flow | $13,744 | $13,915 | $14,015 | $7,931 | $7,929 |
| Beginning Cash Position | 2,124 | 2,124 | 2,124 | 5,584 | 5,584 |
| End Cash Position | 11,141 | 13,394 | 14,415 | 2,124 | 3,806 |
| Net Cash Flow | $9,018 | $11,270 | $12,291 | $-3,460 | $-1,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,729 | -2,648 | -1,725 | -11,389 | -9,700 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -6 |
| Free Cash Flow | -4,729 | -2,648 | -1,725 | -11,389 | -9,706 |